LDN-27219 Modulates High-Glucose-Induced Endothelial Bioenergetic Remodeling and MitoSOX Red Fluorescence
Authors:
- Augusta VolkevičiūtėAVAugusta Volkevičiūtė
- Deimantė PuzinovėDPDeimantė Puzinovė
- Zbigniev BalionZBZbigniev Balion
- Nikolas ŽumbakisNŽNikolas Žumbakis
- Patricija LapinskaitėPLPatricija Lapinskaitė
- Agilė TunaitytėATAgilė Tunaitytė
- Olena KutakhOKOlena Kutakh
- Edgaras StankevičiusEdgaras Stankevičius
- Estéfano PinillaEPEstéfano Pinilla
- Ulf SimonsenUlf Simonsen
Open Access
Abstract
Background: Endothelial dysfunction is a key feature of diabetic vascular disease and is associated with high-glucose-induced changes in endothelial energy metabolism and redox balance. Transglutaminase-2 has been implicated in vascular stress responses, but its contribution to endothelial adaptation to high glucose remains incompletely defined. Methods: EA.hy926 endothelial cells were cultured under normoglycaemic (NG) or high-glucose conditions and treated with LDN-27219 at 20 µg/mL (48.9 µM). Cellular reducing capacity, total protein content, mitochondrial respiration, MitoSOX Red fluorescence, and selected cytokine and adhesion-marker secretion were assessed. Results: High glucose shifted cells toward a more glycolytic basal phenotype, increased MitoSOX Red fluorescence, and reduced glycolytic stress responsiveness compared with NG conditions. LDN-27219 had limited effects under NG conditions but, under high-glucose conditions, reduced basal respiration, maximal respiration, ATP-linked oxygen consumption, and spare respiratory capacity, while partially restoring stressed extracellular acidification. LDN-27219 also reduced high-glucose-induced MitoSOX Red fluorescence, although this cannot be interpreted as definitive evidence of reduced mitochondrial superoxide production because mitochondrial membrane potential was not measured. No statistically significant changes were detected in the selected inflammatory or adhesion markers. Conclusions: LDN-27219 modifies endothelial bioenergetic and oxidant-associated fluorescence responses under high-glucose conditions.Keywords
Funding Information
- Lietuvos Mokslo Taryba (S-MIP-23-94)
This publication has 31 references indexed in Scilit:
- Mitochondrial quality control in diabetes mellitus and complications: molecular mechanisms and therapeutic strategiesCell Death & Disease, 2025
- Endothelial function can be modulated by acute hyperglycemiaScientific Reports, 2025
- Vascular endothelial cell injury: causes, molecular mechanisms, and treatmentsMedcomm, 2025
- Sex-mediated effects of transglutaminase 2 inhibition on endothelial function in human resistance arteries from diabetic and non-diabetic patientsClinical Science, 2025
- Mitochondrial regulation of diabetic endothelial dysfunction: Pathophysiological linksThe International Journal of Biochemistry & Cell Biology, 2024
- Ultrastructural features mirror metabolic derangement in human endothelial cells exposed to high glucoseScientific Reports, 2023
- Neuronal and Endothelial Transglutaminase-2 Expression during Experimental Autoimmune Encephalomyelitis and Multiple SclerosisNeuroscience, 2021
- Organelle dynamics of endothelial mitochondria in diabetic angiopathyEuropean Journal of Pharmacology, 2021
- Mitochondria-Targeted Triphenylphosphonium-Based Compounds: Syntheses, Mechanisms of Action, and Therapeutic and Diagnostic ApplicationsChemical Reviews, 2017
- Quantifying intracellular rates of glycolytic and oxidative ATP production and consumption using extracellular flux measurementsJournal of Biological Chemistry, 2017